A generic, homogenous method for measuring kinase and inhibitor activity via adenosine 5′-diphosphate accumulation

被引:59
作者
Charter, Neil W. [1 ]
Kauffman, Lindy [1 ]
Singh, Raj [1 ]
Eglen, Richard M. [1 ]
机构
[1] DiscoveRx Corp, Fremont, CA 94538 USA
关键词
ADP accumulation; coupled-enzyme assay; serine/threonine protein kinase; tyrosine protein kinase; phosphorylation; inhibitor mode of action; fluorescent detection;
D O I
10.1177/1087057106286829
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The authors describe an assay to measure the generation of adenosine 5'-diphosphate (ADP) resulting from phosphorylation of a substrate by a kinase. ADP accumulation is detected by conversion to a fluorescent signal via a coupled enzyme system. The technology has potential applications for the assessment of inhibitor potency and mode of action as well as kinetic analysis of enzyme activity. The assay has a wide dynamic range (0.25-75 mu M) and has been validated with several kinases including the highly active cyclic adenosine monophosphate-dependent protein kinase (PKA alpha), casein kinase 1 (CK1), and the weakly active kinase Jun N-terminal kinase 2 (Jnk2 alpha 2). Kinase activity can be measured either in an end point or continuous mode. Assay performance in end point mode was compared with an adenosine 5'-triphosphate (ATP) depletion assay and in continuous mode with a pyruvate kinase/lactate dehydrogenase coupled assay. The ability to characterize kinase kinetics was demonstrated by deriving ATP/substrate affinity (Michaelis-Menten constant; K-m) values for PKA alpha, CK1, and Jnk2 alpha 2. The assay readily measured activity with kinase reactions using protein substrates, indicating the suitability for use with large macromolecules. A wide range of inhibitor activities could be determined even in the presence of high ATP concentrations, making the assay highly suitable to characterize the mode of action of the inhibitor in question. Collectively, this assay provides a homogenous, generic method for a number of applications in kinase drug discovery.
引用
收藏
页码:390 / 399
页数:10
相关论文
共 36 条
[1]   A SYNTHETIC PEPTIDE SUBSTRATE SPECIFIC FOR CASEIN KINASE-1 [J].
AGOSTINIS, P ;
PINNA, LA ;
MEGGIO, F ;
MARIN, O ;
GORIS, J ;
VANDENHEEDE, JR ;
MERLEVEDE, W .
FEBS LETTERS, 1989, 259 (01) :75-78
[2]   Studies leading to the identification of ZD1839 (Iressa™):: An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer [J].
Barker, AJ ;
Gibson, KH ;
Grundy, W ;
Godfrey, AA ;
Barlow, JJ ;
Healy, MP ;
Woodburn, JR ;
Ashton, SE ;
Curry, BJ ;
Scarlett, L ;
Henthorn, L ;
Richards, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) :1911-1914
[3]   CHARACTERIZATION OF PP60(C-SRC) TYROSINE KINASE-ACTIVITIES USING A CONTINUOUS ASSAY - AUTOACTIVATION OF THE ENZYME IS AN INTERMOLECULAR AUTOPHOSPHORYLATION PROCESS [J].
BARKER, SC ;
KASSEL, DB ;
WEIGL, D ;
HUANG, XY ;
LUTHER, MA ;
KNIGHT, WB .
BIOCHEMISTRY, 1995, 34 (45) :14843-14851
[4]   Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection [J].
Beasley, JR ;
Dunn, DA ;
Walker, TL ;
Parlato, SM ;
Lehrach, JM ;
Auld, DS .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (03) :455-459
[5]   Development and application of fluorescence polarization assays in drug discovery [J].
Burke, TJ ;
Loniello, KR ;
Beebe, JA ;
Ervin, KM .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2003, 6 (03) :183-194
[6]  
Copeland R. A., 2004, ENZYMES PRACTICAL IN
[7]  
DOMINGUEZ JM, 2002, SOC BIOM SCREEN C TH
[8]   Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].
Druker, BJ ;
Sawyers, CL ;
Kantarjian, H ;
Resta, DJ ;
Reese, SF ;
Ford, JM ;
Capdeville, R ;
Talpaz, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042
[9]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[10]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037